Beta-Blockers Use and Risk of Breast Cancer in Women with Hypertension.

Guoqiao ZhengJan SundquistKristina SundquistJianguang Ji

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)

Breast cancer surveillance is recommended for hypertensive female patients using beta-1 selective blockers.

Keyphrases

blood pressure
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
angiotensin converting enzyme
public health
peritoneal dialysis
angiotensin ii
breast cancer risk